| 0 |
ACHLORHYDRIA |
1 |
0.0143 |
| 1 |
PERITONITIS SCLEROSING |
1 |
0.0120 |
| 2 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 3 |
TONGUE SPASM |
1 |
0.0032 |
| 4 |
HEPATITIS ALCOHOLIC |
1 |
0.0031 |
| 5 |
SENSATION OF BLOOD FLOW |
1 |
0.0026 |
| 6 |
WOUND DRAINAGE |
1 |
0.0013 |
| 7 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 8 |
TEMPORAL ARTERITIS |
1 |
0.0011 |
| 9 |
WRONG SCHEDULE |
1 |
0.0010 |
| 10 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 11 |
NASAL PRURITUS |
1 |
0.0008 |
| 12 |
APPLICATION SITE WARMTH |
1 |
0.0008 |
| 13 |
NASAL DISCOMFORT |
6 |
0.0008 |
| 14 |
IMPETIGO |
1 |
0.0007 |
| 15 |
PATHOLOGICAL GAMBLING |
1 |
0.0006 |
| 16 |
FEAR OF DISEASE |
1 |
0.0006 |
| 17 |
NASAL OEDEMA |
1 |
0.0006 |
| 18 |
INFECTED SKIN ULCER |
1 |
0.0005 |
| 19 |
COMPULSIVE SHOPPING |
1 |
0.0005 |
| 20 |
HEPATIC NEOPLASM MALIGNANT |
1 |
0.0005 |
| 21 |
FEAR OF DEATH |
1 |
0.0004 |
| 22 |
APPLICATION SITE SWELLING |
2 |
0.0004 |
| 23 |
RADICULOPATHY |
1 |
0.0004 |
| 24 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 25 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 26 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 27 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 28 |
TONGUE ULCERATION |
1 |
0.0003 |
| 29 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 30 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 31 |
WOUND COMPLICATION |
1 |
0.0003 |
| 32 |
DEPRESSION SUICIDAL |
1 |
0.0003 |
| 33 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 34 |
SCAB |
3 |
0.0003 |
| 35 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 36 |
TRIGGER FINGER |
1 |
0.0002 |
| 37 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 38 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 39 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 40 |
CATHETERISATION CARDIAC |
1 |
0.0002 |
| 41 |
DRUG EFFECT DELAYED |
1 |
0.0002 |
| 42 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 43 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 44 |
RASH VESICULAR |
1 |
0.0002 |
| 45 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 46 |
DRUG DISPENSING ERROR |
3 |
0.0002 |
| 47 |
MALABSORPTION |
1 |
0.0002 |
| 48 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 49 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 50 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 51 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 52 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 53 |
APPLICATION SITE ERYTHEMA |
4 |
0.0002 |
| 54 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 55 |
DIVERTICULUM |
1 |
0.0001 |
| 56 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 57 |
RASH PUSTULAR |
1 |
0.0001 |
| 58 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 59 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 60 |
RENAL CYST |
1 |
0.0001 |
| 61 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 62 |
ABNORMAL FAECES |
1 |
0.0001 |
| 63 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 64 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 65 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 66 |
HYSTERECTOMY |
1 |
0.0001 |
| 67 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 68 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 69 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 70 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 71 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 72 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 73 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 74 |
EMPHYSEMA |
1 |
0.0001 |
| 75 |
JOINT DISLOCATION |
1 |
0.0001 |
| 76 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 77 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 78 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 79 |
RASH GENERALISED |
2 |
0.0001 |
| 80 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 81 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 82 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 83 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 84 |
HYPOKINESIA |
1 |
0.0001 |
| 85 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 86 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 87 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 88 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 89 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 90 |
CYANOSIS |
1 |
0.0001 |
| 91 |
SCIATICA |
1 |
0.0001 |
| 92 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 93 |
IMPAIRED HEALING |
2 |
0.0001 |
| 94 |
MANIA |
1 |
0.0001 |
| 95 |
SCAR |
1 |
0.0001 |
| 96 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 97 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 98 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 99 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 100 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 101 |
BLISTER |
3 |
0.0001 |
| 102 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 103 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 104 |
GLAUCOMA |
1 |
0.0001 |
| 105 |
HERNIA |
1 |
0.0001 |
| 106 |
ORAL HERPES |
1 |
0.0001 |
| 107 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 108 |
RIB FRACTURE |
1 |
0.0000 |
| 109 |
MOUTH ULCERATION |
1 |
0.0000 |
| 110 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 111 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 112 |
SNEEZING |
1 |
0.0000 |
| 113 |
BURNING SENSATION |
3 |
0.0000 |
| 114 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 115 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 116 |
SKIN ULCER |
1 |
0.0000 |
| 117 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 118 |
PARAESTHESIA |
6 |
0.0000 |
| 119 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 120 |
HAEMOPTYSIS |
1 |
0.0000 |
| 121 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 122 |
ANGINA PECTORIS |
1 |
0.0000 |
| 123 |
HYPERSOMNIA |
1 |
0.0000 |
| 124 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 125 |
RENAL INJURY |
1 |
0.0000 |
| 126 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 127 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 128 |
STOMATITIS |
2 |
0.0000 |
| 129 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 130 |
CYSTITIS |
1 |
0.0000 |
| 131 |
MOOD SWINGS |
1 |
0.0000 |
| 132 |
CHOLELITHIASIS |
1 |
0.0000 |
| 133 |
VIRAL INFECTION |
1 |
0.0000 |
| 134 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 135 |
HYPERKALAEMIA |
1 |
0.0000 |
| 136 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 137 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 138 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 139 |
DYSURIA |
1 |
0.0000 |
| 140 |
DIABETES MELLITUS |
2 |
0.0000 |
| 141 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 142 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 143 |
DYSKINESIA |
1 |
0.0000 |
| 144 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 145 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 146 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 147 |
THROAT IRRITATION |
1 |
0.0000 |
| 148 |
SKIN IRRITATION |
1 |
0.0000 |
| 149 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 150 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 151 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 152 |
DYSPEPSIA |
2 |
0.0000 |
| 153 |
CELLULITIS |
1 |
0.0000 |
| 154 |
SINUSITIS |
2 |
0.0000 |
| 155 |
INFLAMMATION |
1 |
0.0000 |
| 156 |
BRADYCARDIA |
1 |
0.0000 |
| 157 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 158 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 159 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 160 |
HYPONATRAEMIA |
1 |
0.0000 |
| 161 |
HERPES ZOSTER |
1 |
0.0000 |
| 162 |
DYSPHONIA |
1 |
0.0000 |
| 163 |
NASAL CONGESTION |
1 |
0.0000 |
| 164 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 165 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 166 |
PRURITUS |
6 |
0.0000 |
| 167 |
AMNESIA |
1 |
0.0000 |
| 168 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 169 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 170 |
INJURY |
1 |
0.0000 |
| 171 |
EPISTAXIS |
1 |
0.0000 |
| 172 |
HYPOAESTHESIA |
2 |
0.0000 |
| 173 |
HALLUCINATION |
1 |
0.0000 |
| 174 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 175 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 176 |
BACK PAIN |
3 |
0.0000 |
| 177 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 178 |
DRY MOUTH |
1 |
0.0000 |
| 179 |
FALL |
4 |
0.0000 |
| 180 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 181 |
PAIN |
7 |
0.0000 |
| 182 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 183 |
ANXIETY |
3 |
0.0000 |
| 184 |
DYSPHAGIA |
1 |
0.0000 |
| 185 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 186 |
ANAEMIA |
2 |
0.0000 |
| 187 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 188 |
SYNCOPE |
1 |
0.0000 |
| 189 |
SOMNOLENCE |
2 |
0.0000 |
| 190 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 191 |
HYPERTENSION |
2 |
0.0000 |
| 192 |
DEPRESSION |
2 |
0.0000 |
| 193 |
PALPITATIONS |
1 |
0.0000 |
| 194 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 195 |
FEELING ABNORMAL |
2 |
0.0000 |
| 196 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 197 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 198 |
HYPERHIDROSIS |
1 |
0.0000 |
| 199 |
RENAL FAILURE |
1 |
0.0000 |
| 200 |
DEHYDRATION |
1 |
0.0000 |
| 201 |
DRY SKIN |
1 |
0.0000 |
| 202 |
VISION BLURRED |
1 |
0.0000 |
| 203 |
COUGH |
2 |
0.0000 |
| 204 |
DYSPNOEA |
4 |
0.0000 |
| 205 |
INFECTION |
1 |
0.0000 |
| 206 |
RASH |
3 |
0.0000 |
| 207 |
OFF LABEL USE |
6 |
0.0000 |
| 208 |
MALAISE |
3 |
0.0000 |
| 209 |
HOSPITALISATION |
1 |
0.0000 |
| 210 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 211 |
DRUG INTERACTION |
1 |
0.0000 |
| 212 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 213 |
URTICARIA |
1 |
0.0000 |
| 214 |
MUSCLE SPASMS |
1 |
0.0000 |
| 215 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 216 |
CHEST PAIN |
1 |
0.0000 |
| 217 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 218 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 219 |
FATIGUE |
4 |
0.0000 |
| 220 |
ERYTHEMA |
1 |
0.0000 |
| 221 |
ARTHRALGIA |
2 |
0.0000 |
| 222 |
CONSTIPATION |
1 |
0.0000 |
| 223 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 224 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 225 |
DIZZINESS |
2 |
0.0000 |
| 226 |
NAUSEA |
3 |
0.0000 |
| 227 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 228 |
PYREXIA |
1 |
0.0000 |
| 229 |
HEADACHE |
1 |
0.0000 |
| 230 |
DIARRHOEA |
1 |
0.0000 |
| 231 |
DEATH |
1 |
0.0000 |